Alcresta Therapeutics specializes in developing innovative enzyme products for enteral nutrition. Focused on addressing conditions like cystic fibrosis, exocrine pancreatic insufficiency, and short bowel syndrome, the company aims to enhance nutritional outcomes for patients with fat malabsorption and other medical challenges.
Specialties
Enzyme products for enteral nutrition
Treatment for fat malabsorption
Support for cystic fibrosis patients
Innovative digestive enzyme solutions
Focus on rare digestive disorders
Products & Services
Enzyme cartridges for enteral nutrition
Digestive enzyme products
Nutritional solutions for cystic fibrosis
Support for fat malabsorption
Innovative therapies for rare diseases
Contact Information
No contact information available
Competitors & Similar Companies(10)
Abbott Laboratories
Illinois, • United States
Nestlé Health Science
Vaud, • Switzerland
Danone Nutricia
Baxter International
Illinois, • United States
Horizon Therapeutics
Reckitt Benckiser
Purdue Pharma
Connecticut, • United States
Catalent
New Jersey, • United States
Aimmune Therapeutics
California, • United States
Vertex Pharmaceuticals
Massachusetts, • United States
News & Media
Search Terms:
alcresta therapeutics
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Alcresta Therapeutics
Where is Alcresta Therapeutics located?
The headquarter of Alcresta Therapeutics is located in Newton Lower Falls, Massachusetts, United States
What is the official website of Alcresta Therapeutics?
What industry does Alcresta Therapeutics belong to?
Alcresta Therapeutics belongs to the Medical Devices and Equipment, Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Alcresta Therapeutics?
Alcresta Therapeutics specializes in Enzyme products for enteral nutrition, Treatment for fat malabsorption, Support for cystic fibrosis patients, Innovative digestive enzyme solutions, Focus on rare digestive disorders.
What products and services is Alcresta Therapeutics likely to offer?
Alcresta Therapeutics offers Enzyme cartridges for enteral nutrition, Digestive enzyme products, Nutritional solutions for cystic fibrosis, Support for fat malabsorption, Innovative therapies for rare diseases.
Who are the competitors of Alcresta Therapeutics?
Competitors of Alcresta Therapeutics are Abbott Laboratories, Nestlé Health Science, Danone Nutricia, Baxter International, Horizon Therapeutics, Reckitt Benckiser, Purdue Pharma, Catalent, Aimmune Therapeutics, Vertex Pharmaceuticals.
What does Alcresta Therapeutics do?
Alcresta Therapeutics specializes in developing innovative enzyme products for enteral nutrition. Focused on addressing conditions like cystic fibrosis, exocrine pancreatic insufficiency, and short bowel syndrome, the company aims to enhance nutritional outcomes for patients with fat malabsorption and other medical challenges.
What are the social media links of Alcresta Therapeutics?
Social media links of Alcresta Therapeutics areLinkedIn